Sign In
Buy BCRX
$8.25
-0.0900 (-1.08%)
At Close: Jun 03, 2026
BioCryst's Shares March Higher, Can It Continue?
11:53am, Friday, 15'th May 2020
As of late, it has definitely been a great time to be an investor in BioCryst Pharmaceuticals.
BioCryst Celebrates HAE Patients with HAE Global Walk
11:00am, Friday, 15'th May 2020
BioCryst Pharmaceuticals, Inc. (BCRX) today announced companywide activities in support of hae day :-) 2020, a global awareness day for hereditary angioedema (HAE). Since actual community walks canno
BioCryst: What Past Data Says About Galidesivir In SARS-CoV-2
07:57pm, Thursday, 14'th May 2020
BioCryst is up hugely on expectation of positive results for galidesivir in SARS-CoV-2. We discuss available past data of the adenosine analog galidesivir in th
Is BioCryst Pharmaceuticals (BCRX) Stock Outpacing Its Medical Peers This Year?
03:30pm, Wednesday, 13'th May 2020
Is (BCRX) Outperforming Other Medical Stocks This Year?
6 Stock Charts To Watch: AMRS, CYTK, DRNA, LX, MRNA, VAPO
12:00am, Tuesday, 12'th May 2020
Stocks Analysis by Harry Boxer covering: SPDR S&P 500, Amyris Inc, BioCryst Pharmaceuticals Inc, Cytokinetics Inc. Read Harry Boxer's latest article on Investing.com
Here's Why Shares of BioCryst Pharmaceuticals Jumped Higher Today
06:45pm, Monday, 11'th May 2020
Shares of BioCryst Pharmaceuticals (NASDAQ: BCRX) are up 13% at 2:09 p.m., continuing a two-day run that's seen its shares increase 36% since the close on Thursday. It appears investors are excited a
Gilead's COVID-19 drug seen in short supply for Americans - BNN Bloomberg
03:32pm, Monday, 11'th May 2020
The U.S. will get less than half of Gilead Sciences Inc.’s worldwide donation of 1.5 million vials of its COVID-19 medicine over the next six weeks, which isn’t expected to be enough to treat all
Gilead's coronavirus drug will be in short supply for Americans
02:15pm, Monday, 11'th May 2020
WASHINGTON (BLOOMBERG) - The United States will get less than half of Gilead Sciences Inc's worldwide donation of 1.5 million vials of its Covid-19 medicine over the next six weeks, which is not expec
Industry Analysts Just Made A Meaningful Upgrade To Their BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Revenue Forecasts
05:07pm, Thursday, 07'th May 2020
Celebrations may be in order for BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shareholders, with the analysts...
U.S. RESEARCH ROUNDUP-Ashland Global, Lyft, Solaredge Technologies
03:19pm, Thursday, 07'th May 2020
Wall Street securities analysts on Thursday revised their ratings and
price targets on several U.S.-listed companies, including Ashland Global Holdings, Lyft and
Solaredge Technologies.
HIGH
BioCryst to Present at Upcoming Investor Conferences
11:00am, Thursday, 07'th May 2020
RESEARCH TRIANGLE PARK, N.C., May 07, 2020 -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will present at the Bank of America 2020 Healthcare.
U.S. RESEARCH ROUNDUP-Ashland Global Holdings, Lyft, Solaredge Technologies
07:34am, Thursday, 07'th May 2020
Wall Street securities analysts revised their ratings and price targets on
several U.S.-listed companies, including Ashland Global Holdings, Lyft and Solaredge
Technologies, on Thursday.
HIG
Edited Transcript of BCRX earnings conference call or presentation 6-May-20 12:30pm GMT
05:37am, Thursday, 07'th May 2020
Q1 2020 BioCryst Pharmaceuticals Inc Earnings Call
Biocryst Pharmaceuticals Inc (BCRX) Q1 2020 Earnings Call Transcript
11:31pm, Wednesday, 06'th May 2020
Participating with me today are CEO, Jon Stonehouse; CFO, Anthony Doyle; Chief Medical Officer, Dr. Bill Sheridan; Chief Business Officer, Megan Sniecinski; and Chief Commercial Officer, Charlie Gayer
BioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Tops Revenue Estimates
12:55pm, Wednesday, 06'th May 2020
BioCryst (BCRX) delivered earnings and revenue surprises of 7.69% and 78.23%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
